This brochure promotes Hyrimoz® and Erelzi®, biosimilar therapies from Sandoz, highlighting patient support services, easy self-administration with the SensoReady® Pen, and treatment convenience. It showcases features such as extended room-temperature stability, ergonomic injection device design, and a thinner needle option for improved patient comfort. The brochure also introduces the Startz® Patient Support Program, which provides education, training, and ongoing support to help patients manage their treatment effectively.